|Articles|September 1, 1999

The American Journal of Managed Care

  • September 1999
  • Volume 5
  • Issue 9

Is a Third-Trimester Antibody Screen in Rh+ Women Necessary?

Download PDF: Is a Third-Trimester Antibody Screen in Rh+ Women Necessary?

Articles in this issue

over 26 years ago

Was the Decreasing Trend in Hospital Mortality from Heart Failure Attributable to Improved Hospital Care? The Oregon Experience, 1991-1995

over 26 years ago

The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I

over 26 years ago

The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II

over 26 years ago

Selective Contracting and Patient Outcomes: A Case Study of Formulary Restrictions for Selective Serotonin Reuptake Inhibitor Antidepressants

over 26 years ago

Patient Factors Related to the Odds of Receiving Prevention Services in Veterans Health Administration Medical Centers

over 26 years ago

Innovative Healthcare for Chronically Ill Older Persons: Results of a National Survey

over 26 years ago

Office-Based Surgery and Cost Avoidance in an Obstetrics and Gynecology Residency Program

over 26 years ago

Drug Therapy of Allergic Rhinitis

over 26 years ago

Rethinking Formulary Strategy: Management and Measurement Considerations

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text